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ABSTRACT: 
 
Introduction: 
 
Endometriosis is highly prevalent among women of reproductive age increasing up 
to 50% in those presenting with infertility. Ovarian endometriosis, known as 
endometriomas, is found in up to 44% of women with endometriosis. Excisional 
surgery for endometrioma in the form of cystectomy is associated with a reduction in 
ovarian reserve as measured by anti-Müllerian hormone (AMH). Although there are 
reports of recovery of AMH levels following cystectomy, the long-term effects of this 
surgery on ovarian reserve is unknown.  
 
Objective and Methods: 
 
The primary objective is to investigate whether there is recovery of serum anti-
Müllerian hormone (AMH) level in the long-term (more than 1 year) after cystectomy 
for endometriomas, with a secondary objective to determine the on-going pregnancy 
rate in the group of patients trying to conceive. We performed a longitudinal cohort 
study in a tertiary referral unit evaluating fifty-nine patients that underwent 
laparoscopic cystectomy for suspected endometrioma. We analysed data on serum-
AMH levels of samples collected before or on the day of surgery, 6 months after 
surgery and at a mean final follow-up of 23.3 months after surgery. For our 
secondary outcome we determined a documented clinical pregnancy in patients that 
whished to conceive 
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Results:  
 
The serum AMH levels declined in 92% of patients at final follow-up. A significant 
decline in serum AMH of -1.23ng/ml and -1.47ng/ml was detected at 6 months and 
final follow-up respectively. We demonstrated an on-going pregnancy rate of 38% in 
the groups trying to conceive. 
 
Conclusion:  
 
The reduction in ovarian reserve following cystectomy as measured by serum AMH 
does not recover in the overwhelming majority of patients. Patients need to be 
counselled regarding this possibility and alternative fertility sparing options should be 
considered in the management of endometriomas in women still wishing to conceive. 
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CHAPTER 1: Pathophysiology of the endometrioma 
1.1 Introduction: 
 
The prevalence of endometriosis among women of reproductive age ranges between 
6-10% increasing up to 50% in those presenting with infertility.(1) Endometriomas 
are found in up to 44% of women with endometriosis, with which it shares its 
pathogenesis.(2) Although there are numerous hypotheses for the pathogenesis of 
endometriosis, it is now widely accepted that there are three distinct phenotypes of 
the disease in the pelvis. 
 
1.2 Phenotypes: 
 
The first phenotype of endometriosis is so-called peritoneal endometriosis, these 
typical superficial lesions are characterised by proliferative glands with either 
columnar or pseudo-stratified epithelium. In the early stages of endometriosis these 
appear as red lesions that regrows constantly with cyclical hormone fluctuation 
inducing local inflammation. This chronic inflammation induces scar formation 
resulting in enclosure of the implant causing accumulation of debris, and 
development of a typical black endometriotic lesion.(3) 
 
Another phenotype is that of deep-infiltrating endometriosis often involving the recto-
vaginal septum. These lesions are most likely not infiltrating but rather result from 
local metaplasia of residual Müllerian cells embryologically deposited in these areas. 
Lesions often involve a collection of smooth muscle fibres, glandular and stromal 
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endometrial tissue. Proliferation and fibrosis of these smooth-muscle fibres result in 
the typical nodular appearance of these lesions, which can be palpated with vaginal 
or rectal examination.(3) 
 
The third phenotype, and the main focus of this dissertation, is that of ovarian 
endometriosis mostly presenting in cystic form and commonly referred to as an 
ovarian endometrioma. These cysts invariably contain homogenous dark-brown fluid 
of medium consistency. This fluid represents accumulated menstrual debris, and 
have lead to the often used term of “chocolate cyst” to describe this particular 
phenotype.(4)  
 
1.3 Pathogenesis of endometrioma: 
 
The exact pathogenesis of these endometriotic ovarian cysts is still being debated. 
One of the most commonly cited theories for the development of an endometrioma is 
that it results from an endometriotic focus on the surface of the ovary. The 
associated inflammation then causes adhesion between this endometriotic focus and 
the peritoneal surface, most often the posterior aspect of the broad ligament.(5) This 
results in a confined endometriotic deposit that is sensitive to the cycling circulating 
hormones associated with a regular menstrual cycle. After hormonal stimulation of 
these deposits, and subsequent withdrawal, these active endometriotic implants 
shed similar to the endometrium with which it shares its histology. Accumulation of 
this menstrual debris in the occluded space between the ovarian and peritoneal 
surfaces results in invagination of the ovarian cortex at this point.(6) Over time this 
leads to development of an extra-ovarian pseudocyst. This implies that these cysts 
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does not have a true cyst wall, but that what appears macroscopically to be a cyst 
wall, is in actual fact invaginated stretched out ovarian cortex.(4)  
 
An alternative mechanism for the development of an endometrioma relies on the 
metaplasia theory, similar to that of the development of other forms of endometriosis. 
A layer of mesothelium covers the ovarian surface and has been shown on 
histological investigation to invaginate and result in inclusions in the ovary. This 
mesothelial layer is pluripotent and metaplasia of its cells can result in the 
development of intra-ovarian glandular epithelium and stroma akin to endometriosis. 
Similar to the previously discussed mechanism, continuous hormonal stimulation and 
shedding of endometrium, result in accumulation of debris and subsequent cyst 
formation in these inclusion cysts.(7) 
 
A final pathogenic mechanism for the formation of ovarian endometrioma involves 
the transformation of functional ovarian cysts into endometrioma. The most common 
functional cyst implicated in the process is the cystic corpus luteum. It is proposed 
that the inflammation and possible adhesions associated with active peritoneal 
endometriotic implants predetermine the site of ovulation and subsequent corpus 
luteal formation. Potent fibrinolytic agents produced by endometriotic implants could 
predispose to haemorrhagic corpus luteum formation followed by secondary 
colonisation by ectopic endometrial cells.(8) 
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1.4 Conclusion: 
 
Regardless of the exact process of its pathogenesis, it is clear from all available 
literature that the ovarian endometrioma is not a typical ovarian cyst with a well-
defined capsule, but rather a pseudocyst with a capsule that is in fact thinly stretched 
out ovarian cortex.(9) This fact in the pathogenesis of an endometrioma has serious 
implications for its management as any attempt at removal could potentially damage 
or remove some of the residual ovarian tissue with a resultant decrease in functional 
ovarian reserve. 
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CHAPTER 2: Ovarian reserve 
 
2.1 Introduction: 
 
Ovarian reserve is a term used to describe the size of the remaining follicular pool in 
the ovary. A declining follicular pool and oocyte quality is a hallmark of natural 
female ageing, but can also be accelerated by autoimmune disease, endometriosis 
and surgery to the ovary.(10) 
 
2.2 Ovarian reserve tests: 
 
Testing for ovarian reserve aims to quantify or estimate the remaining follicular pool 
in the ovary. Various biological, biochemical, biophysical and even histological tests 
have been described with the aim to quantify the ovarian reserve.(10) 
 
Advancing age is associated with a declining follicular pool, and widely considered a 
biological marker for ovarian reserve. Although age is considered the most import 
factor with regard to fertility potential, it is not suitable for quantifying the effect of 
surgery on ovarian reserve.(10) 
 
Antral follicle count (AFC) is a sonar parameter denoting the number of antral 
follicles as measured with trans-vaginal ultrasound in the early follicular phase. 
Antral follicles are regarded as the follicles with a mean diameter, measured in two 
perpendicular planes, measuring between 2-6mm. AFC is most often used in an 
assisted reproductive setting to predict poor or normal response to ovarian 
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hyperstimulation.(10) AFC has also been used for the quantification of ovarian 
reserve in patients with endometriomas or following ovarian surgery for 
endometriomas. Studies do however raise the question of the accuracy of AFC in the 
case of an operated ovary to accurately predict the ovarian reserve.(11) This query 
along with the logistical issue of timing the AFC ultrasound in the early the follicular 
phase precludes it from being the ideal marker for estimating the effect of surgery on 
ovarian reserve in a research setting. 
 
Density of follicles can be determined histologically from an ovarian biopsy specimen 
obtained at the time of laparoscopy. This follicular density in conjunction with the 
ovarian volume could thus be use estimate the ovarian reserve. The accuracy of an 
ovarian biopsy to quantity the density of follicles is however questionable as follicles 
are not necessarily distributed equally across the ovary and the biopsy might thus 
not be representative of the true density.(10) 
 
Basal follicle stimulation hormone (FSH), produced in the anterior lobe of the 
pituitary gland, can be use as a surrogate marker for ovarian reserve. Inhibin B is a 
glycoprotein hormone secreted by pre-antral follicles. This hormone provides 
negative feedback to the pituitary thus controlling the release of FSH. As the pool of 
pre-antral follicles decrease the amount of negative feedback provided by inhibin B 
decreases, resulting in a subsequent rise in FSH levels.(12) Although no exact cut-
off points exist, high FSH levels in the early follicular phase of the cycle can be used 
to estimate the ovarian reserve and response to stimulation and thus identify a 
diminished ovarian reserve.(12) 
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Other dynamic measures of ovarian reserve such as early follicular estradiol levels 
or the clomiphene citrate challenge test as demonstrated significant inter-cycle 
variability and are thus not reliable markers for routinely measuring ovarian 
reserve.(12) 
 
2.3 Anti-Müllerian Hormone: 
 
Anti-Müllerian hormone (AMH) has been extensively studied as a marker of ovarian 
reserve. AMH is a glycoprotein produced by the granulosa cells in the pre-antral and 
small antral follicles, and therefore provides quantification of the residual follicular 
pool in the ovary.(10,12) AMH correlates well with the clinical antral follicle count. 
This hormone is not usually influenced by follicular development and thus displays 
no inter-cycle variability. AMH can be measured in the serum at any time during the 
menstrual cycle making it a more objective and easy method of measuring the 
ovarian reserve.(10,13) The introduction of measurement of serum levels for AMH by 
enzyme linked immunosorbent assay (ELISA) was initially plagued by technical 
issues. The initial essays displayed complement interference and required modified 
protocols and extensive manual execution, resulting in a lack of standardisation and 
reproducibility of results.(14,15) The recent introduction of standardised automated 
assays has however overcome the initial issues with ELISA AMH testing. These 
automated assay are now producing comparable results and have been externally 
validated.(15)  
 
Currently the main application of AMH is in predicting the ovarian response to 
gonadotropin stimulation during assisted reproductive treatment. This not only allows 
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for the prediction of a poor response but also identifies the patient with a high AMH 
that is at risk of developing ovarian hyperstimulation syndrome.(14) Due to the fact 
that serial determination of AMH can determine the loss of ovarian function, it is 
increasingly being employed to quantify the effect of endometriosis and associated 
ovarian surgery on ovarian reserve.(14,16) 
 
2.4 Conclusion: 
 
Although various methods and modalities for measuring ovarian reserve exit, issues 
of reproducibility and intra- and inter-cycle variability plague most of them. AMH 
however, notwithstanding its limitations, provides the most objective and 
reproducible measure of quantifying the remaining follicle pool and an ideal tool for 
studying the effects of surgical intervention on ovarian reserve. 
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CHAPTER 3: Surgical management of endometrioma 
 
3.1 Introduction: 
 
It has been a long held view that medical management on its own does not 
satisfactorily and definitively treat ovarian endometriomas, and most often do not 
lead to complete resolution of the cyst, but at most a reduction size. Subsequently 
the surgical management of endometriomas is often favoured and has been 
regarded as the standard of care in these cases.(2) 
 
3.2 Aspiration of the endometrioma: 
 
Ultrasound-guided percutaneous drainage, either trans-abdominally or trans-
vaginally, could be regarded as the least invasive surgical modality in the 
management of endometrioma. The biggest drawback to this technique is the high 
recurrence rate reported by several investigators.(2)  
 
More recently some groups have employed ethanol as a sclerosing agent at the time 
of endometrioma aspiration. They report favourable outcomes in endometriomas up 
to the size of 10 cm and propose this as an ovarian sparing approach to the 
management of these cysts. There is however limited data on the effect of this 
technique on ovarian reserve and fertility potential or pregnancy outcome following 
its use.(17) Although promising, the risk of complications such as infection and 
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adhesions and the inability to obtain adequate histology at the time of aspiration 
coupled with a high recurrence rate have led to aspiration not being regarded as a 
first line strategy in the management of endometrioma. One exception to this 
statement could be when considering the management of an endometrioma in the 
context of assisted reproductive treatment involving a patient that as already 
underwent multiple previous surgeries. Additional surgical intervention could further 
delay her infertility treatment and compromise an already diminished ovarian 
reserve. In these cases consideration can be give to conservative treatment in the 
form of aspiration of the endometrioma prior to starting ovarian stimulation with the 
aim of doing in-vitro fertilisation (IVF).(2) 
 
3.3 Cystectomy for endometrioma: 
 
Cystectomy in the context of surgery for an endometrioma refers to the excision of 
the apparent cyst wall performed either at open surgery or more recently and 
preferably at laparoscopic surgery. The current best level of evidence point to this 
excisional approach being superior to less radical intervention such as drainage or 
ablation with regard to recurrence of the endometrioma and pain as well as a 
reported improvement in spontaneous pregnancy rates following cystectomy.(18)  
 
Cystectomy involves the opening and draining of the endometrioma at the time of 
laparoscopy. This is followed by careful identification of the cyst wall, aided by 
laparoscopic magnification, and meticulously stripping it off the ovarian parenchyma, 
utilising two atraumatic laparoscopic forceps with traction and counter-traction 
developing and following a cleavage plane.(19) Given the accepted pathophysiology 
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of an endometrioma, as already discussed in the opening chapter, there is often a 
lack of a clearly defined surgical plane. This is firstly due to pseudo-cystic nature of 
the endometrioma itself, not possessing an anatomically defined cyst wall, and 
secondly due to associated endometriosis induced fibrosis that surrounds the 
cyst.(20) Excisional surgery thus has a high risk of inadvertently removing ovarian 
parenchyma especially in regions with dense fibrosis where it can be extremely 
difficult to find a good cleavage plane.(20) This potential removal of healthy and 
viable ovarian tissue has been studied by evaluating the histological specimens of 
cystectomies performed for endometriomas for the presence of ovarian stroma and 
follicles. Presence of ovarian tissue could be confirmed in 40 to 100% of histology 
samples following cystectomies.(19–21) Although this loss of ovarian tissue could 
contribute to the loss of ovarian function, the effects of excision or stripping of the 
cyst could be exaggerated by the concomitant vascular compromise in the remaining 
ovarian tissue. This would most likely be caused by injudicious use of bipolar 
coagulation or any other energy source on the remaining raw ovarian surface to 
achieve haemostasis resulting in a destruction of functional ovarian tissue and 
reduced ovarian reserve.(21,22) 
 
3.4 Cystectomy and ovarian reserve: 
 
It is clear from the literature reviewed thus far that excisional surgery for 
endometrioma in the form of cystectomy could compromise the ovarian reserve. 
Somigliana et al systematically reviewed 11 articles investigating the effect of 
excisional management of ovarian endometriomas utilising the stripping technique 
on ovarian reserve as measured by AMH. Nine of the 11 studies demonstrated a 
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statistically significant decline in AMH following surgery.(23) AMH decline has been 
reported up to six month after the index surgery. The magnitude of the decline in 
AMH level was also more pronounced in cases where bilateral cystectomy was 
performed for endometrioma, or where the cysts being removed were larger than 5 
cm.(16,24)  
 
The concept that ovarian reserve can recover after cystectomy has been discussed 
in the literature before.(25) Previous studies reporting on serial changes in AMH 
values following ovarian cystectomy for endometrioma have suggested that levels 
could recover at one year after surgery. Vignali et al. evaluated 22 patients and did 
not demonstrate any difference between AMH levels pre-operatively and at 12 
months after cystectomy.(26) Another study evaluating the recovery of ovarian 
reserve after cystectomy reported an increase in AMH level in 51% of patients at 1 
year.(27)  
 
3.5 Conclusion: 
 
Although the mere presence of ovarian endometriosis could influence the function of 
the immediate adjacent ovarian parenchyme, the pathogenesis of an ovarian 
endometrioma dictates that excisional surgery invariable should have a negative 
effect on the surrounding viable ovarian tissue. The disease itself or surgical 
technique as well as the size and presence of bilateral cysts could influence the 
degree of the reduction in ovarian reserve. Recovery of this resultant insult to the 
ovarian reserve has however not been adequately studied. 
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CHAPTER 4: A Cohort Study: Long-term effect on ovarian 
reserve of surgery for endometrioma   
 
4.1 Introduction: 
 
Although cystectomy is regarded as the preferred management of endometrioma 
(18), it is currently being questioned because of the possibility that it could remove 
ovarian tissue due to the absence of a clearly defined cyst capsule.(28) This along 
with the resultant vascular compromise could result in a decrease in ovarian 
reserve.(22) Although this decline in ovarian reserve as measured by AMH has been 
well proven in the short-term (23), there is a paucity of data relating to the long-term 
effects of ovarian cystectomy for endometrioma. 
 
4.2 Aim: 
 
This study aims to determine the long-term effects of ovarian surgery on ovarian 
reserve. It studies a cohort of patients undergoing ovarian cystectomy for 
endometrioma followed-up over an extended period of longer than a year with the 
main aim to determine the long-term impact of surgery for endometriomas on the 
ovarian reserve as reflected by AMH. We aimed to determine the recovery or failure 
to recover of serum-AMH levels at long-term follow-up, as well the reproductive 
outcomes in these patients.  
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4.3 Objectives: 
 
The primary objective was to determine the trend in serum-AMH levels after 12 
months in patients that underwent laparoscopic ovarian cystectomy for 
endometriomas. The secondary objective was to determine the reproductive 
outcome in those patients that were trying to conceive. 
 
4.4 Materials and Methods: 
 
The patients in this study were previously recruited as part of a prospective cohort 
study evaluating changes in AMH 6 months after laparoscopic cystectomy.(29) The 
current study presents a long-term (>12 month) follow-up of this cohort and reports a 
3rd AMH value at >12 months as well as their reproductive outcomes up to the last 
follow-up date. 
 
Patients were recruited before surgery and included if they had sonographic features 
suggestive of uni- or bilateral endometrioma. Clinical and demographic data were 
collected and all surgery was done laparoscopically at a tertiary referral centre. 
Patients were excluded if the intra-operative findings did not confirm the presence of 
an endometrioma in at least one of the ovaries. 
 
Surgery was performed under general anaesthesia. A standard 4 port laparoscopic 
approach involved establishing a pneumoperitoneum with a Verres needle and 
closed primary entry at the umbilicus followed by placement of additional ports under 
direct vision. Surgery involved appropriate adhesiolysis and mobilisation of ovaries 
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from the ovarian fossae. The endometrioma was opened with monopolar energy and 
its content aspirated. Cystectomy was performed by gentle traction and counter-
traction with two atraumatic graspers taking care of the cleavage plane and avoiding 
damage to ovarian cortex. At the areas where no clear plane could be identified the 
surface of the cyst was ablated using an argon beam coagulator. If needed, 
haemostasis was achieved by applying the argon beam coagulator. The rest of the 
procedure involved addressing any concurrent peritoneal and recto-vaginal 
endometriosis by ablation or excision. All specimens were sent for histologic 
confirmation of endometriosis.  
 
Initial serum AMH values were determined pre-operatively or on the day of surgery 
and again at 6 months following the surgery.  At long-term follow-up (>12 months 
after surgery), serum AMH was again determined. Persistence of any symptoms as 
well as recurrence of endometrioma was noted. Patients that had repeated 
cystectomy during the follow-up period were excluded in the final analysis of AMH 
values. The reproductive outcomes of patients after the initial surgery were also 
recorded. 
 
4.5 Data management: 
 
Data was extracted from patient files and laboratory results pertaining to the study 
question. Data was extracted with a custom-made data extraction tool and entered 
into an EXCEL spreadsheet and presented for statistical analysis. 
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Three AMH assays were used during the course of this study namely the AMH GenII 
(Beckman Coulter), Access (Beckman Coulter) and Elecsys (Roche). The majority of 
samples were tested using the automated Elecsys platform. All other results were 
converted by using the Passing-Bablock regression equations described by Nelson 
et al (15) before statistical analysis, to allow for accurate comparison of all values.  
 
Data was analysed with STATA 14 (STATACorp) and WIZARD 1.9.13 (E.MILLER) 
data analysis software. A random effects model was used to compare values at 
different times. We used the Student’s t test to compare changes in values between 
different groups.   
 
4.6 Ethical approval: 
 
Ethical approval for this study was obtained from the Health Research Ethics 
Committee of the Faculty of Medicine and Health Sciences of Stellenbosch 
University, protocol no S17/02/027. 
 
4.7 Results: 
 
A total of 59 patients were recruited to undergo surgery for suspected 
endometrioma. At surgery 7 patients were found not to have an endometrioma and 2 
patients were lost to follow-up, thus 50 patients were included for analysis at a final 
mean follow-up period of 23.3 months (95% CI, 20.9-25.8) after surgery. The mean 
age of patients was 34.4(±6.07) with the majority (68%) having a unilateral 
Stellenbosch University  https://scholar.sun.ac.za
		 17	
endometrioma and 54% (n=27) also had recto-vaginal endometriosis. The baseline 
characteristics are represented in Table 1.  
 
For the primary outcome evaluating the long-term effect on ovarian reserve following 
cystectomy, 26 patients with 3 AMH values were included. These values were 
measured at surgery, 6 months after surgery and at final follow-up respectively. The 
pre-operative, 6-month and final follow-up AMH levels were 2.60±1.76/1.56 
(mean±SD/median), 1.36±0.71/1.28 and 1.13±0.82/1.02, respectively. This 
represents a statistically significant decline of -1.23(95%CI:-1.84 - -0.62; P<0.001) at 
6 months and -1.47(95%CI:-2.08 - -0.86: P<0.001) at final follow-up. Twenty-four 
patients (92%) showed a decline of their AMH levels equating to an overall decline of 
50.5% (95%CI:34.9-66.0) in the mean AMH levels at final follow-up.  
 
Bilateral endometriomas were associated with a significantly greater reduction in 
AMH values with a mean reduction of -2.79±1.98ng/ml compared to -0.77±0.49ng/ml 
in patients with unilateral endometriomas (P=0.008). In those patients with a decline 
in AMH value at final follow-up this represents a reduction of 38.9±20.6% for 
unilateral and 72.2±18.5% for bilateral endometriomas respectively (P=0.033).  
 
A large number of patients (n=34) were actively trying to conceive following the 
surgery, with an on-going pregnancy rate of 38% (n=13) during the follow-up period. 
The majority of pregnancies were conceived spontaneously (54%, n=7).  
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CHAPTER 5: Discussion, limitations and conclusion 
 
5.1 Discussion: 
 
There is growing consensus in the literature that an ovarian endometrioma is not a 
true cyst of the ovary but rather an invagination of the ovarian cortex by progressive 
accumulation of menstrual debris from active endometriotic deposits.(3,7,4) The 
origin of this endometriotic focus is however still debated with the two most popular 
theories being that of a superficial implant resulting from retrograde menstruation, as 
proposed by Sampson, or metaplasia occurring in the mesothelium lining of an 
ovarian inclusion cysts.(7) Regardless of the exact pathophysiology, the absence of 
a true cyst wall results in significant adherence to underlying ovarian parenchyma, 
with no clearly defined cleavage plane. (5) 
 
Previous studies with variable length of follow-up after surgery have reported that 
ovarian reserve could potentially recover after the initial drop shortly after the 
surgery.(25,26) Our study is unique because of the long follow-up period of AMH 
levels that extends to a mean of 23.3 months (95% CI, 20.9-25.8). Over this 
extended period we have failed to demonstrate a recovery in AMH values at final 
follow-up, but rather a further decline (1.23±1.06ng/ml) compared to the values at 6 
months after surgery (1.36±0.94ng/ml).  
 
Few studies have evaluated the pregnancy rate in patients trying to conceive after 
cystectomy for endometriomas. Taniguchi et al. reported a cumulative pregnancy 
rate of 50% among 40 patients undergoing laparoscopic cystectomy for ovarian 
Stellenbosch University  https://scholar.sun.ac.za
		 19	
endometrioma.(30) In our study we found an on-going pregnancy rate of 38% 
(13/34) among women trying to conceive after surgery. Seven of the pregnancies 
were spontaneous, 2 required ovulation induction and 4 resulted from in-vitro 
fertilisation. Previous studies have shown the preoperative AMH levels are not 
predictive of pregnancy rates following endometriosis surgery.(31) We demonstrated 
no statistical difference in pre-operative or final follow-up of AMH between patients 
achieving pregnancy and those who did not. 
 
It has become clear that the traditional technique of cystectomy for the 
endometrioma could have a detrimental effect on ovarian reserve and reduce 
subsequent fertility (23,32). Other surgical approaches in the management of 
endometriomas might reduce the impact on ovarian reserve. Hydro-dissection with 
or without the addition if dilute vasopressin have been suggested to aid in identifying 
the correct surgical plane thus possibly reducing the risk of inadvertently removing 
normal ovarian tissue.(33,34) Vasopressin, as vasoconstrictor, has the added benefit 
of limiting the need for excessive coagulation to achieve haemostasis and in this way 
limits potential damage to ovarian reserve.(33,35) Another alternative would include 
the combined technique involving partial stripping of the cyst wall with ablation of any 
residual endometriotic foci at the more vascular hilar area.(36,37) Alternatively, 
especially in the very large endometrioma, a 3-step approach with initial laparoscopic 
drainage followed by GnRH suppression for 3 months and ablation of the base of the 
cyst at repeat laparoscopy could be used in an attempt to limit damage to the 
ovary.(7) 
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Although much controversy still exists, it seems that cystectomy for endometrioma 
does not improve the outcome of in vitro fertilisation cycles (IVF), and thus 
proceeding with ART prior to extensive surgery should be considered.(38,39) In such 
cases thought should be given to offering medical suppression of the endometriosis 
with gonadotropin releasing hormone agonists (GnRHa) followed by controlled 
ovarian hyperstimulation and IVF.(40) Although this may be suitable for women with 
an immediate desire for pregnancy, in those that would like to delay conception, 
ovarian stimulation with oocyte vitrification might be an option to protect their future 
fertility before undergoing extensive endometriosis surgery.(41) This should 
especially be considered in younger patients with bilateral or recurrent 
endometriomas.  
 
There are however clinical scenarios where complete cystectomy could be indicated 
and individualisation in these cases are needed. One of the disadvantages of not 
performing a cystectomy is the absence of histology confirming the benign nature of 
the cyst.(42) The association of the histological finding of atypical endometriosis and 
the development of clear cell and endometrioid carcinoma of the ovary contributes to 
a growing view that these lesions could be regarded as premalignant.(43) The 
presence of enhanced mural nodularity in ovarian endometrioma have also been 
associated with histological findings of malignancy.(44) Recurrence of 
endometriomas is associated with an increased risk of developing atypical 
endometriosis.(45,46) Taking all of these factors into consideration there may be a 
place for more radical surgery in the patient older than forty years of age, not 
desiring fertility, presenting with recurrent endometriomas or imaging that reveals 
mural nodularity.(46) 
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5.2 Limitations: 
 
A large number of the patients initially recruited into the study did not have 3 AMH 
values for comparison in the final analysis. This limitation is a result of the relatively 
high cost of the AHM assay in South Africa leading to many of the participants failing 
to repeat the investigations as requested. We do however include the long-term 
reproductive outcome of our cohort as a secondary outcome. 
 
5.3 Conclusion: 
 
The current available data does not report an initial negative effect on pregnancy 
rate after cystectomy for endometrioma. The long-term reproductive effect may 
however be dramatic. This is the first study to report on the long-term trend of serum 
AMH values following surgery for endometrioma and aims to address the paucity of 
data in this regard. With the negative impact on ovarian reserve due to traditional 
cystectomy for endometrioma now well proven, consideration of alternative surgical 
approaches such as hydro-dissection, the combined, 3-step technique or drainage 
alone in cases where fertility desire exist may be considered. One should be 
especially cautious in cases of bilateral or recurrent endometriomas, as the resultant 
loss of ovarian reserve after surgery could be dramatic. We again demonstrated the 
association of recto-vaginal endometriosis with endometrioma in more than half of 
patients. The potential finding of severe endometriosis should be anticipated when 
planning surgery in these cases and consideration given to the level of skill of the 
surgeon as well as involvement of a multi-disciplinary team and additional pre-
operative assessment. Pre- and post-operative AMH determination should be done 
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and this information used in the counselling of patients to discuss the effects of 
surgery, fertility prognosis and alternative strategies such as oocyte vitrification. 
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ADDENDUM 
 
Table 1: 
Characteristics of patients with endometrioma 
(n=50) 
 
Mean(±SD) n(%) 
   
Age (y) 34.4(±6.07) 
 
BMI (kg/m2) 25.3(±4.56) 
 
Previous Surgery 
  
   Endometrioma 
 
13(26) 
   Endometriosis 
 
16(32) 
Indication for Surgery 
  
   Pain and Infertility 
 
14(28) 
   Pain only 
 
30(60) 
   Infertility only 
 
6(12) 
Concurrent Endometriosis 
  
   Peritoneal 
 
27(54) 
   Rectovaginal 
 
27(54) 
Endometrioma 
  
   Unilateral 
 
34(68) 
   Bilateral 
 
16(32) 
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Table 2: 
Mean AMH ng/ml(±SD) according to clinical 
findings. 
    
Endometrioma   Unilateral   Bilaterlal 
P 
value 
 
(n=19) (n=7) 
 
0 months 2.05±0.82 3.64±2.11 0.071 
6 month 1.48±0.54 1.16±0.51 0.427 
Final f/up 1.28±0.59 0.85±0.65 0.342 
    Endometriosis Pertoneal Rectovaginal 
 
 
(n=11) (n=16) 
 
0 months 3.60±0.81 2.29±0.97 
 
6 month 1.66±0.79 1.24±0.46 
 
Final f/up 1.17±0.95 1.19±0.59 
 
 
Table 3: 
Reproductive Outcome 
 
n(%) 
  
Trying to conceive 34 
Pregnancies 13(38) 
Spontaneous 7(54) 
Assisted 6(46) 
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